The frequency of WT1 deletions was significantly higher in WTs that later relapse than in the group without relapse (21 versus 6.4 %); one tumor from a patient who relapsed was found to carry both WTX and WT1 deletions. This evidence concerns the gene WT1 and neoplasm.